Uncategorized

PRICERA is a proprietary compound shown to enter the NAD+ biosynthetic pathway directly, efficiently increasing NAD+ levels throughout the body, including muscle and brain tissues. Study conducted by: American Preclinical Services, Minneapolis, MN; Alex Xue, PhD, BioE Life Science, Inc., Minneapolis, MN. Key Findings 1. Pharmacodynamics of PRICERA Study Design: PRICERA metabolites, including NAD+, NMN, and NR, [...]

1. PRICERA Utilizes a Naturally Dominant Pathway for Robust NAD+ Generation PRICERA is the only commercially available compound that harnesses a naturally dominant pathway to generate NAD+ more robustly. Our body synthesizes NAD+ through three major pathways: De novo synthesis from tryptophan: This involves converting the amino acid tryptophan, sourced from dietary proteins, into NAD+. [...]

Pricera has a proven itself with practitioners for over 5 years and has several advantages over NMN (and regular NR), especially in terms of stability, bioavailability, and its ability to target multiple aging biomarkers. Here’s a chart summarizing key advantages: Key Advantages of Pricera: PRICERA NR NMN Direct Precursor of NAD ✔ ✔ ✔ Increases NAD ✔ ✔ ✔ [...]

Pricera has a proven itself with practitioners for over 5 years and has several advantages over NMN, especially in terms of stability, bioavailability, and its ability to target multiple aging biomarkers. Here’s a summary of it's key points: Key Advantages of Pricera: FDA cGRAS Certified Ribose: Ensures product safety and purity, meeting Health Canada ingredient requirements and European [...]